Ongoing Trials Studying Immunotherapy as a First-Line Treatment in Head and Neck Cancer
October 3rd 2016Barbara Ann Burtness, MD, professor of medicine, Clinical Research Program Leader, Head and Neck Cancers Program and Co-Director, Developmental Therapeutics Research Program at Yale Cancer Center, discusses the ongoing trials looking at immunotherapy as a first-line treatment in head and neck cancer.
Watch
The Need for Better Surrogate Parameters for Overall Survival in Colorectal Cancer
October 3rd 2016Volker Heinemann, MD, PhD, director of the Comprehensive Cancer Center at Ludwig Maximilian University of Munich, discusses the need for better surrogate parameters for overall survival in colorectal cancer.
Watch
The Potential Role of Immunotherapy in the Management of Breast Cancer
October 3rd 2016Lajos Pusztai, MD, professor of medicine, chief of Breast Medical Oncology, Yale Cancer Center, and Co-Director, Yale Cancer Center Genetics, Genomics and Epigenetics Program, discusses the potential role of immunotherapy in the management of breast cancer.
Watch
The Role of Immunotherapy in Breast Cancer
September 25th 2016Hope Rugo, MD, clinical professor, department of medicine, and director of Breast Oncology Clinical Trials Program, at University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses the role of immunotherapy in breast cancer.
Watch
Questions That Remain Regarding Combination, Sequencing With PARP Inhibitors
September 25th 2016Patricia LoRusso, DO, PhD, professor of medicine and associate director of Innovative Medicine at Yale Cancer Center, discusses the key questions that still remain regarding combination and sequencing with PARP inhibitors.
Watch